Cargando…

Seven tumor‐associated autoantibodies as a serum biomarker for primary screening of early‐stage non‐small cell lung cancer

OBJECTIVE: The purpose of this study was to analyze the levels of tumor‐associated autoantibodies (TAAbs) in lung diseases and determine their diagnostic efficiency in early‐stage non‐small cell lung cancer (NSCLC). METHODS: We retrospectively analyzed the levels of 7‐TAAbs in 177 newly diagnosed ea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ping, Lu, Wei, Chen, Tingting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605152/ https://www.ncbi.nlm.nih.gov/pubmed/34555232 http://dx.doi.org/10.1002/jcla.24020

Ejemplares similares

The role of seven autoantibodies in lung cancer diagnosis
por: Luo, Bin, et al.
Publicado: (2021)

Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer
por: Jin, Yingji, et al.
Publicado: (2017)

Clinical value of seven autoantibodies combined detection in the diagnosis of lung cancer
por: Mu, Yinyu, et al.
Publicado: (2020)

Prevalence of serum galectin-1 autoantibodies in seven types of cancer: A potential biomarker
por: Nanami, Tatsuki, et al.
Publicado: (2021)

Application Value Analysis of Seven-Autoantibody Panel in the Lung Cancer Screening in Yunnan
por: Li, Wenrun, et al.
Publicado: (2022)

Screening of autoantibodies as biomarkers in the serum of renal cancer patients based on human proteome microarray: Screening of autoantibodies in renal cancer
por: Sun, Yangyang, et al.
Publicado: (2022)

Measuring serum human epididymis secretory protein autoantibody as an early biomarker of lung cancer
por: Yang, Bin, et al.
Publicado: (2020)

Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting
por: Chen, Hongda, et al.
Publicado: (2016)

Plasma small ncRNA pair panels as novel biomarkers for early-stage lung adenocarcinoma screening
por: Dou, Yuhong, et al.
Publicado: (2018)

Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features
por: Xu, Leidi, et al.
Publicado: (2022)

Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk?
por: Wang, Minmin, et al.
Publicado: (2021)

Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis
por: Tang, Zhen-Ming, et al.
Publicado: (2017)

Identification and Validation of Novel Serum Autoantibodies Biomarkers for Staging Liver Fibrosis in Patients With Chronic Hepatitis B
por: Qi, Saiping, et al.
Publicado: (2022)

A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer
por: Hong, Chao-Qun, et al.
Publicado: (2021)

Paraneoplastic Antigen Ma2 Autoantibodies as Specific Blood Biomarkers for Detection of Early Recurrence of Small Intestine Neuroendocrine Tumors
por: Cui, Tao, et al.
Publicado: (2010)

Serum Anti-CCNY Autoantibody Is an Independent Prognosis Indicator for Postoperative Patients with Early-Stage Nonsmall-Cell Lung Carcinoma
por: Ma, Li, et al.
Publicado: (2013)

Abnormal methylation of seven genes and their associations with clinical characteristics in early stage non-small cell lung cancer
por: ZHAO, YANGXING, et al.
Publicado: (2013)

Autoantibodies against tumor-associated antigens in sputum as biomarkers for lung cancer
por: Li, Ning, et al.
Publicado: (2020)

Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced Adenoma
por: Wang, Hejing, et al.
Publicado: (2020)

The Implication of Serum Autoantibodies in Prognosis of Canine Mammary Tumors
por: Yuan, Stephen Hsien-Chi, et al.
Publicado: (2022)

Role of biochemical markers and autoantibodies in diagnosis of early-stage primary biliary cholangitis
por: Zhu, Yu-Jin, et al.
Publicado: (2023)

Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer
por: Duan, Guo-Chen, et al.
Publicado: (2020)

Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer
por: Geng, Qing, et al.
Publicado: (2014)

Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma
por: Li, Yang, et al.
Publicado: (2020)

Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer
por: Chen, Zhong-qing, et al.
Publicado: (2018)

A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection
por: Dumstrei, Karin, et al.
Publicado: (2016)

Detection of brain-directed autoantibodies in the serum of non-small cell lung cancer patients
por: Banjara, Manoj, et al.
Publicado: (2017)

Serum Autoantibody Biomarkers for Management of Rheumatoid Arthritis Disease
por: Sánchez-Tirado, Esther, et al.
Publicado: (2023)

Are sputum autoantibodies more clinically relevant in idiopathic pulmonary fibrosis than serum autoantibodies?
por: Deng, Kuimiao, et al.
Publicado: (2022)

A tumor-associated autoantibody panel for the detection of non-small cell lung cancer
por: Cai, Ruijun, et al.
Publicado: (2022)

The combination of a seven-autoantibody panel with computed tomography scanning can enhance the diagnostic efficiency of non-small cell lung cancer
por: He, Tianyu, et al.
Publicado: (2022)

Serum Anti-14-3-3 Zeta Autoantibody as a Biomarker for Predicting Hepatocarcinogenesis
por: Wang, Ting, et al.
Publicado: (2021)

Serum lipidome screening in patients with stage I non-small cell lung cancer
por: Klupczynska, Agnieszka, et al.
Publicado: (2019)

Use of anchorchip-time-of-flight spectrometry technology to screen tumor biomarker proteins in serum for small cell lung cancer
por: Du, Jie, et al.
Publicado: (2010)

Tumor-associated autoantibodies as diagnostic and prognostic biomarkers
por: Heo, Chang-Kyu, et al.
Publicado: (2012)

Serum anti-GAPDH autoantibody levels reflect the severity of cervical lesions: A potential serum biomarker for cervical cancer screening
por: Xu, Mei Ling, et al.
Publicado: (2019)

Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma
por: Welberry, Christopher, et al.
Publicado: (2020)

Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2018)

Circulating and tissue biomarkers in early-stage non-small cell lung cancer
por: Fumagalli, Caterina, et al.
Publicado: (2017)

Biomarkers predictive value in early stage non-small cell lung cancer
por: Malapelle, Umberto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0rejo9egunrknhh7f07q8mvv0e